News
Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.
Due to the technological conditions and application demands of that time, although artificial intelligence appeared during the Third Industrial Revolution, it did not have a significant impact on ...
Good morning, everyone, and welcome to the FirstRand's Annual Results Presentation for the year ended June 2025. Let's start with the operating environment. The macroeconomic environment over the last ...
Non-essential amino acids such as glutamine have been known to be required for T cell general activation through sustaining basic biosynthetic processes, including nucleotide biosynthesis, ATP ...
This study illustrates a valuable application of BID-seq to bacterial RNA, allowing transcriptome-wide mapping of pseudouridine modifications across various bacterial species. The evidence presented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results